General Archive
-
Funding: Translational Innovation Hub Network for Lung Health and Infection in Cystic Fibrosis
Funding: Translational Innovation Hub Network for Lung Health and Infection in Cystic Fibrosis (This funding call is now closed) With…
-
Funding: LifeArc-CSO fund for Scottish translational researchers
Funding: LifeArc-CSO fund for Scottish translational researchers In association with the Chief Scientist Office (CSO) for the Scottish Government, we…
-
Funding: LifeArc and GOSH charity fund
Funding: LifeArc and GOSH charity fund LifeArc and GOSH Charity support a joint funding scheme focused on helping GOSH researchers…
-
Funding: LifeArc and Action Medical research fund
Funding: LifeArc and Action Medical research fund Action Medical Research and LifeArc want to improve the lives of children suffering…
-
Funding: Repurposing therapies for epidermolysis bullosa (EB)
Funding: Repurposing therapies for epidermolysis bullosa (EB) LifeArc and DEBRA Austria are partnering to commit £2.5 million to fund projects…
-
Funding: Translational Rare Disease Centres
Funding: Translational Rare Disease Centres With this £40 million we aim to build on the UK’s rich, rare disease research…
-
Muscular Dystrophy Translational Research Fund
Muscular Dystrophy Translational Research Fund The Muscular Dystrophy Translational Research Fund is a joint fund created by LifeArc and Muscular…
-
Funding: CF AMR Syndicate funding call for new cystic fibrosis therapies
Funding: CF AMR Syndicate funding call for new cystic fibrosis therapies LifeArc, as part of the CF AMR Syndicate, is…
-
Funding: Drug repurposing call to treat chronic respiratory infection
Funding: Drug repurposing call to treat chronic respiratory infection LifeArc has committed £10m to fund up to five consortia programmes…
-
The MND collaborative partnership
The MND collaborative partnership £4.25 million partnership aimed at speeding up the development of effective MND treatments. Overview This exciting…
-
Funding: Development of repurposed drug candidates for MND
Funding: Development of repurposed drug candidates for MND Through LifeArc’s Translational Challenge in MND, this funding programme aims to boost…
-
Funding: £1m primer fund to accelerate MND diagnosis
Funding: £1m primer fund to accelerate MND diagnosis The primer fund is intended to support projects which seek to develop…